Summary Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before, potentially resulting in a 15% CAGR in FreeStyle Libre sales by ...

The market increasingly favours closed-loop tech with extended sensor life, real-time glucose visibility and intelligent ...

Abbott’s ABT diversified business portfolio appears to be well-positioned to drive continued momentum in 2025. The stock carries a Zacks Rank #2 (Buy) currently. Factors Driving ABT Shares Within ...

Abbott's mixed reality technology helps distract blood donors and reduce their anxiety levels. This can help encourage young ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...

We'll still need healthcare products and services in the future, whether we're talking about 10 or 100 years from now. The ...

The American Diabetes Association, now endorses automated insulin delivery (AID) systems as the leading approach for ...

Abbott is poised to release its second-quarter results next month, and analysts project a single-digit earnings growth.

Abbott Elementary, from its first episode, did not hesitate to reach for greatness, and the Quinta Brunson-created comedy’s Season 3 premiere showcases multiple reasons why the show is primed to ...

A further €3.19 billion was spent on work linked to infrastructure projects. Published on June 23, 2025, at 1:14 pm (Paris), updated on June 23, 2025, at 2:31 pm Le Monde with AFP ...